Pharmacy Times: CATALYST Trial Shows Hypercortisolism in 24% of Poorly Controlled Diabetes Patients, Opening New Treatment Avenues Posted on July 5, 2024 at 9:20 am.Shared by contributor Ralph DeFronzo, MD, Department of Medicine, chief of the Division of Diabetes, was quoted in this article. Read More Share This Article!